The Therapeutic Goods Administration added eight new medicine ingredients to its approved list and tweaked the labelling requirements for some others.

The newly added ingredients are C11-13 alkane, cetearyl nonanoate, dimeticonol, disodium lauril sulfosuccinate, methyl heptanoate, polyglyceryl-2 caprate, polyquatermium-4 and resveratrol.

The agency also eased restrictions on labelling for Brilliant Blue FCF, neopentyl glycol dioctanoate, polyvinyl acetate and streptococcus salivarius.